FDAAA

E647146

FDAAA is a U.S. federal law enacted in 2007 that expanded the Food and Drug Administration’s authority over drug and device safety, clinical trial registration, and post-market surveillance.

Try in SPARQL Jump to: Statements Referenced by

Statements (48)

Predicate Object
instanceOf United States federal law
drug regulation law
health law
medical device regulation law
abbreviationFor Food and Drug Administration Amendments Act of 2007 NERFINISHED
affects clinical investigators
clinical trial sponsors
medical device manufacturers
pharmaceutical manufacturers
aimsTo improve drug safety monitoring
increase transparency of clinical research
strengthen post-market surveillance
amends Federal Food, Drug, and Cosmetic Act NERFINISHED
authorizes FDA to require Risk Evaluation and Mitigation Strategies
FDA to require post-marketing clinical trials
FDA to require post-marketing studies
containsProvision Section 801 – Expanded Clinical Trial Registry Data Bank NERFINISHED
Title VIII – Clinical Trial Databases NERFINISHED
country United States of America
surface form: United States
creates Risk Evaluation and Mitigation Strategies program NERFINISHED
effectiveIn United States NERFINISHED
enactedBy United States Congress
establishes expanded post-marketing safety authorities for FDA
expandsAuthorityOf U.S. Food and Drug Administration NERFINISHED
fullName Food and Drug Administration Amendments Act of 2007 NERFINISHED
hasKeyConcept Risk Evaluation and Mitigation Strategies (REMS) NERFINISHED
clinical trial registry
clinical trial results database
post-market risk management
jurisdiction federal
regulates biological products
clinical trial registration
clinical trial results reporting
drug safety
medical device safety
post-market device surveillance
post-market drug surveillance
requires adverse event reporting for certain trials
registration of applicable clinical trials on ClinicalTrials.gov
results reporting for certain clinical trials on ClinicalTrials.gov
submission of basic summary results information
signedBy George W. Bush
signingDate 2007-09-27
subjectArea clinical research regulation
medical device regulation
pharmaceutical regulation
public health
yearEnacted 2007

Referenced by (1)

Full triples — surface form annotated when it differs from this entity's canonical label.